TN2016000064A1 - Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes - Google Patents

Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Info

Publication number
TN2016000064A1
TN2016000064A1 TN2016000064A TN2016000064A TN2016000064A1 TN 2016000064 A1 TN2016000064 A1 TN 2016000064A1 TN 2016000064 A TN2016000064 A TN 2016000064A TN 2016000064 A TN2016000064 A TN 2016000064A TN 2016000064 A1 TN2016000064 A1 TN 2016000064A1
Authority
TN
Tunisia
Prior art keywords
dimethylpropan
aminium
carboxy
ethyl
pharmaceutically acceptable
Prior art date
Application number
TN2016000064A
Inventor
Helena Cirule
Maija Dambrova
Ivars Kalvins
Edgars Liepins
Elina Makarova
Ilga Misane
Ilmars Stonans
Original Assignee
Grindeks Joint Stock Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Joint Stock Company filed Critical Grindeks Joint Stock Company
Publication of TN2016000064A1 publication Critical patent/TN2016000064A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine

Abstract

Use of3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium and its pharmaceutically acceptable salts to decrease blood plasma levels of insulin and glucose.
TN2016000064A 2013-09-26 2014-09-15 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes TN2016000064A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13186201 2013-09-26
PCT/IB2014/064514 WO2015044828A1 (en) 2013-09-26 2014-09-15 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Publications (1)

Publication Number Publication Date
TN2016000064A1 true TN2016000064A1 (en) 2017-07-05

Family

ID=49231372

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2016000064A TN2016000064A1 (en) 2013-09-26 2014-09-15 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Country Status (9)

Country Link
CN (1) CN105530929B (en)
AR (1) AR099638A1 (en)
BR (1) BR112016004211B1 (en)
CA (1) CA2924682C (en)
JO (1) JO3333B1 (en)
MX (1) MX368505B (en)
TN (1) TN2016000064A1 (en)
WO (1) WO2015044828A1 (en)
ZA (1) ZA201600894B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2067474A1 (en) * 2007-12-05 2009-06-10 Grindeks, a joint stock company Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate
LV14345B (en) 2009-10-22 2011-07-20 Grindeks, A/S 4-[ethyl(dimethyl)ammonio]butanoate and their use in the treatment of cardiovascular diseases
HUE030415T2 (en) * 2011-04-27 2017-05-29 Grindeks Jsc Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease

Also Published As

Publication number Publication date
CA2924682C (en) 2018-02-27
BR112016004211B1 (en) 2022-09-06
CA2924682A1 (en) 2015-04-02
CN105530929B (en) 2018-03-02
ZA201600894B (en) 2017-05-31
CN105530929A (en) 2016-04-27
AR099638A1 (en) 2016-08-10
JO3333B1 (en) 2019-03-13
BR112016004211A2 (en) 2017-08-01
WO2015044828A1 (en) 2015-04-02
MX368505B (en) 2019-10-04
MX2016003347A (en) 2016-06-24

Similar Documents

Publication Publication Date Title
PH12015500115A1 (en) Glucagon analogues
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
MX356728B (en) Pharmaceutical combination for use in the treatment of diabetes type 2.
GB201314512D0 (en) Dual Haemodialysis and Haemodiafiltration blood treatment device
SA517381678B1 (en) Dihydropyrimidin-2-One Compounds and Medical Use Thereof
HK1223529A1 (en) Low glucose treatment for people with diabetes
MX2016011881A (en) Dry-powder peptide medicament.
WO2014152754A3 (en) Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
UA118474C2 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
TN2016000064A1 (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes
MX2013009456A (en) Vinyl -aryl - sulfones for use in peritoneal carcinomatosis.
SI2699545T1 (en) Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
SG10201809418VA (en) New administration routes of insulin, insulin analogs or derivatives of insulin
PH12015500306A1 (en) Arry-520 for use in treating cancer in a patient with low aag
PL2852400T3 (en) An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes
AU2014903587A0 (en) Regulation of a blood glucose level in a patient with diabetes
PH12015500178B1 (en) Injectable supersaturated acetaminophen solution for spinal administration
IN2014DE00818A (en)
UA74052U (en) Method for preventing lateral abdominal wall hernia in patients with functioning colostoma and ventral hernia
GB201304462D0 (en) Therapeutic vaccine for treatment of type 2 diabetes and impaired glucose tolerance
UA86338U (en) Method for treating gestational diabetes
UA97741C2 (en) Method for regeneration of skin integuments in patients with deep burns by microautodermotransplants
UA79303U (en) use of taurine as agent for stabilizing the concentration in blood plasma in the treatment of fungal diseases
UA84195U (en) Method for treating influenza in adult patients
UA97054C2 (en) Method for the treatment of patients with dependence owing to application of psychoactive substances